Tag: Vaccine

A long-watched Parkinson’s therapy got a jumpstart last week with a major deal that puts more resources behind the program. In 2012, funded by The...
New study results from Austrian biotech AFFiRiS support continued development of its vaccine against the key Parkinson’s protein alpha-synuclein. To...
Austrian biotech company AFFiRiS AG has announced a €6 million euro (more than $8 million US dollars) grant from the European Union to continue deve...

SIGN UP FOR EMAIL UPDATES

GET PARKINSON'S RESEARCH NEWS, FOUNDATION UPDATES, INVITATIONS TO EVENTS AND MORE.